Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Yield10 Bioscience to Present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference
-
Yield10 Bioscience Inc (YTEN) PT Raised to $24 at Maxim Group
-
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
-
Yield10 Bioscience, Inc. (YTEN) Prices 1.04M Share Offering at $12.25/Sh
-
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
-
Yield10 Bioscience Announces Proposed Public Offering of Common Stock
-
Yield10 Bioscience Announces Closing of $4.0 Million Public Offering, Including Exercise of the Over-Allotment Option, and Concurrent $1.7 Million Private Placement
-
Yield10 Bioscience, Inc. (YTEN) Prices 835K Common Share Offering at $4.25/Sh; Announces Concurrent Private Placement
-
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement
-
Yield10 Bioscience, Inc. (YTEN) Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
-
Yield10 Bioscience Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
-
Yield10 Bioscience Inc (YTEN) PT Lowered to $0.50 at Maxim Group
-
Maxim Group Assumes Yield10 Bioscience Inc (YTEN) at Buy
-
Maxim Group Starts Yield10 Bioscience Inc (YTEN) at Buy

